1. Home
  2. LAC vs FTRE Comparison

LAC vs FTRE Comparison

Compare LAC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lithium Americas Corp.

LAC

Lithium Americas Corp.

N/A

Current Price

$3.03

Market Cap

1.0B

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.82

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAC
FTRE
Founded
2023
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.3B
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
LAC
FTRE
Price
$3.03
$17.82
Analyst Decision
Hold
Buy
Analyst Count
7
9
Target Price
$6.14
$14.06
AVG Volume (30 Days)
8.6M
1.7M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$2.66
$7.40
52 Week High
$10.52
$21.39

Technical Indicators

Market Signals
Indicator
LAC
FTRE
Relative Strength Index (RSI) 42.49 46.71
Support Level $2.67 $17.37
Resistance Level $4.04 $18.13
Average True Range (ATR) 0.14 1.21
MACD 0.06 -0.23
Stochastic Oscillator 34.88 22.06

Price Performance

Historical Comparison
LAC
FTRE

About LAC Lithium Americas Corp.

Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: